8 Results for "

Isoquinoline derivatives

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Isoquinoline derivatives" in MCE Product Catalog:

Cat. No.: HY-144452
CAS No.: 2755772-63-3
Purity:  99.59%
Target:  

Proteasome

Research Areas:  

Cancer

Immunoproteasome inhibitor 1 is a potent, reversible, time-independent immunoproteasome and proteasome inhibitor (Kis of 1.18, 0.27, 1.91 μM in β5c, β1i, β5i submits, respectively). Immunoproteasome inhibitor 1 can be used for the research of certain neoplastic diseases .
loading...
    loading...
Cat. No.: HY-W004698
CAS No.: 628692-15-9
(2-Methoxypyrimidin-5-yl)boronic acid is a drug intermediate that can serve as a key reactant in the Suzuki-Miyaura coupling reaction, and is used for the synthesis of isoquinoline ketone derivatives with anti-tumor activity .
loading...
    loading...
Cat. No.: HY-172530
Research Areas:  

Neurological Disease

Heptanoyl-coenzyme A (Heptanoyl-CoA) tetrasodium is a derivative of CoA. Heptanoyl-coenzyme A tetrasodium is an inhibitor of butyryl-CoA acetate-CoA transferase (BUT) and inhibits butyric acid synthesis. Heptanoyl-coenzyme A tetrasodium blocks the improvements in motor function induced by the isoquinoline alkaloid Berberine (HY-N0716) .
loading...
    loading...
Cat. No.: HY-114814A
CAS No.: 610782-83-7
Target:  

Adrenergic Receptor

Research Areas:  

Others

(+)-ORM-10921 Free base is a compound that exhibits significant biological activity, particularly in the context of chemical synthesis studies and the preparation of pyrido [1,2-b] isoquinoline derivatives. (+)-ORM-10921 Free base is utilized as an active reagent in multi-component reactions involving alkynes and isoquinolinium ylides. (+)-ORM-10921 Free base plays a crucial role in the advancement of synthetic organic chemistry by enabling the formation of complex molecular structures.
loading...
    loading...
Cat. No.: HY-162962
Research Areas:  

Cancer

IDO1/TDO-IN-7 (Compound 43b), an isoquinoline derivative, is a potent dual IDO1/TDO inhibitor, with IC50s of 0.31 μM and 0.08 μM, respectively. IDO1/TDO-IN-7 displays acceptable pharmacokinetic profiles and potent antitumor efficacy with low toxicity in B16-F10 tumor model .
loading...
    loading...
Cat. No.: HY-168623
Research Areas:  

Cancer

EGFR-IN-134 (compound 3f), a triazolo[3,4-a]isoquinoline derivative, is a potent EGFR inhibitor with an IC50 of 0.023 µM. EGFR-IN-134 induces apoptosis and necrosis. EGFR-IN-134 initiates cell cycle arrest at the G2/M and pre-G1 phases, downregulates anti-apoptotic protein Bcl2 and upregulates pro-apoptotic proteins: p53, Bax, and caspases 3, 8, and 9. EGFR-IN-134 shows antiproliferative and anticancer activity .
loading...
    loading...
Cat. No.: HY-118587
CAS No.: 55393-37-8
Synonyms: HE 165
Target:  

Drug Derivative

Research Areas:  

Cardiovascular Disease

CH-102 (HE 165) is an isoquinoline derivative. CH-102 exhibits significant anti-platelet aggregation and antithrombotic activities. CH-102 can be used in the study of angina pectoris .
loading...
    loading...
Cat. No.: HY-181745
Target:  

Bacterial

Research Areas:  

Infection

Pks13-IN-3 is a furo[2,3-b]isoquinoline derivative and Pks13 inhibitor with an IC50 of 1.12 μM. Pks13-IN-3 reduces inhibition of the hERG ion channel. Pks13-IN-3 can be used for the research of tuberculosis .
loading...
    loading...